131
Effekt-2 – Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
Condition(s):Blood Coagulation Disorders; Hemophilia ALast Updated:January 19, 2015Completed
Factor VIII: 881 Clinical Trials, Page 14 of 89
Hide Studies Not Open or Pending
132
Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
Condition(s):Hemophilia ALast Updated:April 20, 2015Completed
133
Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Condition(s):Hemophilia ALast Updated:December 28, 2007Completed
134
An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.
Condition(s):Haemophilia ALast Updated:February 15, 2018Completed
135
Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens
Condition(s):Severe Haemophilia ALast Updated:December 11, 2014Unknown status
136
Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.
Condition(s):Haemophilia ALast Updated:October 16, 2007Completed
137
A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.
Condition(s):Haemophilia ALast Updated:February 15, 2018Completed
138
International PMS Study – KOGENATE Bayer
Condition(s):Hemophilia ALast Updated:June 30, 2009Completed
139
Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
Condition(s):Hemophilia ALast Updated:December 19, 2020Completed
140
A Gene Transfer Study for Hemophilia A
Condition(s):Hemophilia ALast Updated:July 18, 2022Recruiting